Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Fingerprint
Dive into the research topics where Alessandro Laganà is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation (Journal of Hematology & Oncology, (2022), 15, 1, (109), 10.1186/s13045-022-01330-3)
Elnaggar, M., Agte, S., Restrepo, P., Ram, M., Melnekoff, D., Adamopoulos, C., Stevens, M. M., Kappes, K., Leshchenko, V., Verina, D., Jagannath, S., Poulikakos, P. I., Parekh, S. & Laganà, A., Dec 2023, In: Journal of Hematology and Oncology. 16, 1, 52.Research output: Contribution to journal › Comment/debate
Open Access -
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
Mouhieddine, T. H., Van Oekelen, O., Melnekoff, D. T., Li, J., Ghodke-Purani, Y., Lancman, G., Thibaud, S., Pan, D., Rajeeve, S., Agte, S., Aleman, A., Sanchez, L., Richard, S., Rossi, A., Richter, J., Cho, H. J., Rodriguez, C., Lagana, A., Moshier, E., Chari, A., & 2 others, 28 Mar 2023, In: Blood advances. 7, 6, p. 1056-1064 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
The genome of IMiD-refractory myeloma
Laganà, A., 9 Feb 2023, In: Blood. 141, 6, p. 560-561 2 p.Research output: Contribution to journal › Editorial
Open Access -
Artificial Intelligence for Precision Oncology
Bhalla, S. & Laganà, A., 2022, Advances in Experimental Medicine and Biology. Springer, p. 249-268 20 p. (Advances in Experimental Medicine and Biology; vol. 1361).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
7 Scopus citations -
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma
Restrepo, P., Bhalla, S., Ghodke-Puranik, Y., Aleman, A., Leshchenko, V., Melnekoff, D. T., Agte, S., Jiang, J., Madduri, D., Richter, J., Richard, S., Chari, A., Cho, H. J., Jagannath, S., Walker, C. J., Landesman, Y., Laganà, A. & Parekh, S., 1 Jun 2022, In: JCO Precision Oncology. 6, e2200147.Research output: Contribution to journal › Article › peer-review
5 Scopus citations
Press/Media
-
Novel approach brings hospice-bound MM patient into remission
29/09/22
1 item of Media coverage
Press/Media
-
Novel approach brings hospice-bound MM patient into remission
29/09/22
1 item of Media coverage
Press/Media
-
Three-gene signature predicts selinexor response in patients with multiple myeloma
13/07/22
1 item of Media coverage
Press/Media
-
Three Genes That Indicate a Potential Response to Selinexor Myeloma Therapy
Samir Parekh & Alessandro Laganà
6/07/22
1 item of Media coverage
Press/Media
-
Mount Sinai Researchers Discover Genes That Predict Good Response to Blood Cancer Therapy
Samir Parekh & Alessandro Laganà
16/06/22 → 17/06/22
2 items of Media coverage
Press/Media